ArticleVirus genes2026
Exploring potential gene signatures in dengue through machine learning and deep learning approaches.
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is a major public health problem that affects millions of people globally. The present study used microarray data to identify differentially expressed genes (DEGs) during dengue clinical conditions. The microarray datasets GSE84331, GSE18090, GSE43777, and E-MTAB-3162 were downloaded and analyzed using statistical analysis (Unpaired t-test). This was followed by Machine Learning (ML) and Deep Learning (DL) techniques with recursive feature elimination and genetic algorithms implemented to identify the potential biomarkers. Further, functional enrichment, platelet signaling, and protein-protein interaction (PPI) network analysis were performed to explore the potential diagnostic markers associated with dengue. Among all ML/DL models, the Random Forest algorithm outperformed on baseline data and identified 27 DEGs in the dengue fever (DF) vs. control (C) group and 13 DEGs in filtered data of the severe dengue (SD) vs. DF group. Likewise, the Support Vector Machine with Genetic Algorithm (SVM-GA) hybrid model outperformed the SD vs. C group and identified 79 DEGs. Based on the analysis, the study identified seven hub genes such as PIK3R1, GATA3, ZFPM, SKAP1 (involved in hemostasis, platelet activation, aggregation, and production), TP63, ZBTB20, and ZEB2 (abnormal hard palate morphology) for dengue diagnosis. Further, the hub genes may facilitate the development of reliable diagnostic potential; their prognostic utility requires further validation in larger, more diverse cohorts.
Indexed as
Identifiers
41329415What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.